| Intuitive Machines Reports Third Quarter 2026 Financial Results; Reports Record Financials Across The Board - Revenue, Profitability, Positive Cash Flow, and Backlog |
Globe Newswire |
11/12 |
07:30 |
| Base Carbon Reports Third-Quarter 2026 Operating and Financial Results |
Globe Newswire |
11/12 |
07:30 |
| Drones Drive Strong ENVX Revenue Growth |
Globe Newswire |
11/12 |
07:30 |
| Cormedix Therapeutics Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
07:30 |
| ZenaTech’s ZenaDrone Signs MOU with Rattler Medical to Develop Drone-Based Battlefield Blood Delivery System |
Globe Newswire |
11/12 |
07:30 |
| HydroGraph Receives Final Court Order Approving Redomicile Transactions |
Globe Newswire |
11/12 |
07:30 |
| Creative Realities Signs Exclusive Agreement with Toyota/Lexus Canada to Power the Dealership Digital Experience |
Globe Newswire |
11/12 |
07:30 |
| Uniti Demonstrates Industry’s First Single-Fiber 800G Service, Simplifying High-Capacity Connectivity for Customers |
Globe Newswire |
11/12 |
07:30 |
| Solo Brands, Inc. Announces Fiscal 2026 Third Quarter Results |
Globe Newswire |
11/12 |
07:30 |
| Ascendis Pharma Reports Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
07:30 |
| MediPharm Labs Reports Q3 2026 Results with Second Consecutive Quarter of Positive Net Income and 18% Sequential Revenue Growth |
Globe Newswire |
11/12 |
07:30 |
| Dyadic’s C1-Produced RSV and Malaria Antibodies Advance into Animal Studies Following Positive Independent Evaluations |
Globe Newswire |
11/12 |
07:30 |
| Nexxen Reports Record Third Quarter 2026 Financial Results |
Globe Newswire |
11/12 |
07:30 |
| Profusa Announces Progress Towards Satisfying the Conditions to Close of the Option Agreement with G3 |
Globe Newswire |
11/12 |
07:30 |
| Bread Financial to Participate in the TD Cowen 2026 Financials & Fintech Conference |
Globe Newswire |
11/12 |
07:30 |
| Taysha Gene Therapies Reports Third Quarter 2026 Financial Results and Provides Corporate Update |
Globe Newswire |
11/12 |
07:30 |
| Sagimet Biosciences Reports Third Quarter 2026 Financial Results and Provides Corporate Updates |
Globe Newswire |
11/12 |
07:30 |
| Vor Bio Expands Strategic Partnership with RemeGen, Adding Next Generation, Long-Acting RC298 to BAFF/APRIL Franchise |
Globe Newswire |
11/12 |
07:30 |
| Cerenome to Review REYOBIQ ReSPECT-LM Data Presented at SNO Conference and Provide CNSide Commercial Update on November 16 |
Globe Newswire |
11/12 |
07:30 |
| Altimmune Announces Third Quarter 2026 Financial Results and Business Update |
Globe Newswire |
11/12 |
07:30 |
| Quantum X Labs Joins the Global Race by Publishing Updated Execution Roadmap for Building its Cold-Atom Quantum Computer, Targeting Fault-Tolerant Computing by 2030 |
Globe Newswire |
11/12 |
07:25 |
| Generate Biomedicines Reports Third Quarter 2026 Financial Results and Provides Business Update |
Globe Newswire |
11/12 |
07:20 |
| Nasdaq Confirms Hydrofarm's Compliance with Stockholders’ Equity Requirement |
Globe Newswire |
11/12 |
07:15 |
| RCM Technologies, Inc. Announces Third Quarter 2026 Results |
Globe Newswire |
11/12 |
07:15 |
| Altimmune Announces Publication of IMPACT Phase 2b 48-Week Data in MASH in The Lancet Gastroenterology & Hepatology |
Globe Newswire |
11/12 |
07:15 |